Docket Nexus — Federal court records.
Company · Pharmaceuticals & Biotechnology

Amgen Inc

Federal civil lawsuits naming Amgen Inc, a Pharmaceuticals & Biotechnology company.

Ticker
Nasdaq: AMGN
Business
Biological Products, (No Diagnostic Substances)
Headquarters
Thousand Oaks, CA
Incorporated in
Delaware
SEC CIK
318154

Amgen Inc is a public company in Biological Products, (No Diagnostic Substances), based in Thousand Oaks, CA (traded on Nasdaq as AMGN, incorporated in Delaware). It appears in 279 federal civil lawsuits in this index, most often as a defendant (148 of 279). These cases are most often Patent and Patent - ANDA matters, filed between 1992 and 2026, most frequently in District Court, D. Delaware. The most common causes of action are Patent Infringement, Antitrust, and Employment. Frequent opposing parties include Sandoz Inc, Schering Corporation, and Genentech, Inc.

279
Lawsuits
148
As Defendant
131
As Plaintiff
22
Open
257
Terminated
1992–2026
Span
13 mo
Median Duration
8.0 cases/yrNamed as defendant in 53% of casesRecent filings steady

Cases by State

AL — 1 casesAZ — 0 casesAR — 0 casesCA — 50 casesCO — 5 casesCT — 1 casesDE — 73 casesDC — 8 casesFL — 12 casesGA — 3 casesID — 0 casesIL — 12 casesIN — 0 casesIA — 1 casesKS — 0 casesKY — 0 casesLA — 2 casesME — 0 casesMD — 2 casesMA — 15 casesMI — 1 casesMN — 3 casesMS — 1 casesMO — 0 casesMT — 0 casesNE — 1 casesNV — 0 casesNH — 0 casesNJ — 40 casesNM — 0 casesNY — 16 casesNC — 2 casesND — 0 casesOH — 1 casesOK — 1 casesOR — 1 casesPA — 5 casesRI — 0 casesSC — 2 casesSD — 0 casesTN — 1 casesTX — 4 casesUT — 0 casesVT — 0 casesVA — 6 casesWA — 4 casesWV — 2 casesWI — 2 casesWY — 0 cases
PR · 1

Open Cases Over Time

1992peak 35 open2026

Case Types Over Time

19922026
PatentPatent - ANDAFederal Tax / Statutory ActionsContractAntitrust

Filings by Year

19922026

279 Cases — Newest First

Showing 101–150 of 279